IBDEI1GX ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23749,1,4,0)
 ;;=4^N60.32
 ;;^UTILITY(U,$J,358.3,23749,2)
 ;;=^5015780
 ;;^UTILITY(U,$J,358.3,23750,0)
 ;;=N81.6^^82^1032^119
 ;;^UTILITY(U,$J,358.3,23750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23750,1,3,0)
 ;;=3^Rectocele w/o Uterine Prolapse
 ;;^UTILITY(U,$J,358.3,23750,1,4,0)
 ;;=4^N81.6
 ;;^UTILITY(U,$J,358.3,23750,2)
 ;;=^259590
 ;;^UTILITY(U,$J,358.3,23751,0)
 ;;=Z90.11^^82^1032^9
 ;;^UTILITY(U,$J,358.3,23751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23751,1,3,0)
 ;;=3^Acq Absence,Breast,Right
 ;;^UTILITY(U,$J,358.3,23751,1,4,0)
 ;;=4^Z90.11
 ;;^UTILITY(U,$J,358.3,23751,2)
 ;;=^5063582
 ;;^UTILITY(U,$J,358.3,23752,0)
 ;;=Z90.12^^82^1032^8
 ;;^UTILITY(U,$J,358.3,23752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23752,1,3,0)
 ;;=3^Acq Absence,Breast,Left
 ;;^UTILITY(U,$J,358.3,23752,1,4,0)
 ;;=4^Z90.12
 ;;^UTILITY(U,$J,358.3,23752,2)
 ;;=^5063583
 ;;^UTILITY(U,$J,358.3,23753,0)
 ;;=Z90.13^^82^1032^7
 ;;^UTILITY(U,$J,358.3,23753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23753,1,3,0)
 ;;=3^Acq Absence,Breast,Bilateral
 ;;^UTILITY(U,$J,358.3,23753,1,4,0)
 ;;=4^Z90.13
 ;;^UTILITY(U,$J,358.3,23753,2)
 ;;=^5063584
 ;;^UTILITY(U,$J,358.3,23754,0)
 ;;=Z98.82^^82^1032^22
 ;;^UTILITY(U,$J,358.3,23754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23754,1,3,0)
 ;;=3^Breast Implant Status
 ;;^UTILITY(U,$J,358.3,23754,1,4,0)
 ;;=4^Z98.82
 ;;^UTILITY(U,$J,358.3,23754,2)
 ;;=^5063747
 ;;^UTILITY(U,$J,358.3,23755,0)
 ;;=Z12.39^^82^1032^124
 ;;^UTILITY(U,$J,358.3,23755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23755,1,3,0)
 ;;=3^Screening,Oth,Malig Neop,Breast
 ;;^UTILITY(U,$J,358.3,23755,1,4,0)
 ;;=4^Z12.39
 ;;^UTILITY(U,$J,358.3,23755,2)
 ;;=^5062686
 ;;^UTILITY(U,$J,358.3,23756,0)
 ;;=Z80.3^^82^1032^74
 ;;^UTILITY(U,$J,358.3,23756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23756,1,3,0)
 ;;=3^Family Hx of Breast CA
 ;;^UTILITY(U,$J,358.3,23756,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,23756,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,23757,0)
 ;;=Z80.49^^82^1032^75
 ;;^UTILITY(U,$J,358.3,23757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23757,1,3,0)
 ;;=3^Family Hx of Genital Organ CA
 ;;^UTILITY(U,$J,358.3,23757,1,4,0)
 ;;=4^Z80.49
 ;;^UTILITY(U,$J,358.3,23757,2)
 ;;=^5063351
 ;;^UTILITY(U,$J,358.3,23758,0)
 ;;=Z80.41^^82^1032^76
 ;;^UTILITY(U,$J,358.3,23758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23758,1,3,0)
 ;;=3^Family Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,23758,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,23758,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,23759,0)
 ;;=N89.8^^82^1032^101
 ;;^UTILITY(U,$J,358.3,23759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23759,1,3,0)
 ;;=3^Noninflamm D/O,Vagina,Other Spec
 ;;^UTILITY(U,$J,358.3,23759,1,4,0)
 ;;=4^N89.8
 ;;^UTILITY(U,$J,358.3,23759,2)
 ;;=^88111
 ;;^UTILITY(U,$J,358.3,23760,0)
 ;;=N76.2^^82^1032^139
 ;;^UTILITY(U,$J,358.3,23760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23760,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,23760,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,23760,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,23761,0)
 ;;=N76.3^^82^1032^140
 ;;^UTILITY(U,$J,358.3,23761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23761,1,3,0)
 ;;=3^Vulvitis,Subacute and Chronic
 ;;^UTILITY(U,$J,358.3,23761,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,23761,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,23762,0)
 ;;=N95.2^^82^1032^134
